EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study

Chang-Hoon Koo, Soowon Lee, Subin Yim, Yu Kyung Bae, Insun Park, Ah-Young Oh

Anaesthesia Critical Care & Pain Medicine · 2024-12 · 43 (6) · 101445

DOI: 10.1016/j.accpm.2024.101445 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Anaesthesia Critical Care & Pain Medicine, 2024-12. Verfasst von Chang-Hoon Koo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea; Department of Anaesthesiology and…. Hauptthemen laut MEDLINE: Sugammadex, Neuromuscular Monitoring, Neuromuscular Blockade, Anesthesia Recovery Period. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Some anaesthetists wonder whether confirming a train-of-four ratio (TOFR) ≥0.9 is necessary when using sugammadex to antagonise neuromuscular blockade (NMB). In this study, we aimed to determine whether using sugammadex at the recommended dose under neuromuscular monitoring (NMM) would ensure complete recovery, even without further NMM. METHODS: This prospective observational study included 51 patients who underwent robot-assisted surgery under general anaesthesia between March and May 2023. At the end of surgery, sugammadex was administered (2 mg/kg for a train-of-four (TOF) count ≥1 and 4 mg/kg for a TOF count = 0 and a post-tetanic count ≥1). NMM was discontinued, and subsequent recovery was completed at the discretion of the attending anaesthetist. TOFR was measured twice immediately upon admission to the post-anaesthesia care unit (PACU). The primary outcome was the incidence of a non-normalised TOFR (nTOFR)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SugammadexNeuromuscular MonitoringNeuromuscular BlockadeAnesthesia Recovery PeriodNeuromuscular Nondepolarizing AgentsHumansProspective StudiesMaleFemaleMiddle AgedAgedAdultAnesthesia, General

Stichwörter der Autor:innen

NeuromuscularQuantitativeSugammadex

Substanzen

SugammadexNeuromuscular Nondepolarizing Agents

Autor:innen und Institutionen

  • Department of Anaesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea; Department of Anaesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul,…
  • Department of Anaesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.

Zitieren

APA

Koo, C. H., Lee, S., Yim, S., Bae, Y. K., Park, I., & Oh, A. Y. (2024). Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study. Anaesthesia Critical Care & Pain Medicine, 43(6), 101445. https://doi.org/10.1016/j.accpm.2024.101445

Vancouver

Koo CH, Lee S, Yim S, Bae YK, Park I, Oh AY. Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study. Anaesthesia Critical Care & Pain Medicine. 2024;43(6):101445. doi:10.1016/j.accpm.2024.101445

BibTeX
@article{Koo2024,
  author = {Koo, Chang-Hoon and Lee, Soowon and Yim, Subin and Bae, Yu Kyung and Park, Insun and Oh, Ah-Young},
  title = {Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study},
  journal = {Anaesthesia Critical Care & Pain Medicine},
  year = {2024},
  volume = {43},
  number = {6},
  pages = {101445},
  doi = {10.1016/j.accpm.2024.101445}
}
Kostenlos starten →